CHAMPIONS ONCOLOGY, INC. Earnings Per Share Diluted

Quick Answer

CHAMPIONS ONCOLOGY, INC. reported Earnings Per Share Diluted of $0.33 per share for the year ending 2025.

  • CHAMPIONS ONCOLOGY, INC. showed an increase of +161.1% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 23, 2025.
  • XBRL data for this metric is available from 2014 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2014 to 2025), CHAMPIONS ONCOLOGY, INC.'s Earnings Per Share Diluted has grown by 400.0%.
  • Historical annual values: Fiscal year 2025: $0.33 per share | Fiscal year 2024: $0.54 (loss) per share | Fiscal year 2023: $0.39 (loss) per share | Fiscal year 2022: $0.04 per share | Fiscal year 2021: $0.02 per share | Fiscal year 2020: $0.18 (loss) per share | Fiscal year 2019: $0.01 per share | Fiscal year 2018: $0.13 (loss) per share | Fiscal year 2015: $0.18 (loss) per share | Fiscal year 2014: $0.11 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: